Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Memorial Sloan Kettering Cancer Center
Columbia University
Abramson Cancer Center at Penn Medicine
Peking University First Hospital
St. Jude Children's Research Hospital
University Hospital, Rouen
Laikο General Hospital, Athens
Masonic Cancer Center, University of Minnesota
Peking Union Medical College Hospital
St. Jude Children's Research Hospital
The University of Texas Health Science Center at San Antonio
Nanjing First Hospital, Nanjing Medical University
Peking University First Hospital
AC Camargo Cancer Center
Fudan University
University of Pennsylvania
Grupo Espanol de Tumores Neuroendocrinos
British Columbia Cancer Agency
Seoul National University Hospital
Society for Endocrinology
University of Texas Southwestern Medical Center
Radboud University Medical Center
Peking Union Medical College Hospital
Fundación de investigación HM
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Universidad Nacional Autonoma de Mexico
Northwell Health
King's College Hospital NHS Trust
University of Avignon
Peking Union Medical College Hospital
Mayo Clinic
University of California, Los Angeles
Peking Union Medical College Hospital
Children's Hospital Medical Center, Cincinnati
Asan Medical Center
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Rigshospitalet, Denmark
Assistance Publique Hopitaux De Marseille
Radio Isotope Therapy of America
Excel Diagnostics and Nuclear Oncology Center
Peking Union Medical College Hospital
British Columbia Cancer Agency
Assistance Publique - Hôpitaux de Paris
Nanjing First Hospital, Nanjing Medical University
University of Iowa
University Medical Centre Ljubljana
M.D. Anderson Cancer Center